Ureter Carcinoma clinical trials at UCSD
1 research study open to new patients
open to eligible people ages 18 years and up
The purpose of the ATLAS study is to determine how patients with locally advanced unresectable or metastatic urothelial carcinoma respond to treatment with rucaparib.
La Jolla, California and other locations